MicroRNA 4308 (MIR4308)

MicroRNA 4308 (MIR4308) is a human microRNA, part of a large family of short (∼22 nucleotide), single-stranded, non-coding RNAs that modulate gene expression primarily by binding to complementary sites on target messenger RNAs, leading to mRNA degradation or inhibition of translation[3][4][5]. MicroRNAs, including MIR4308, are processed from primary transcripts through Drosha/DGCR8 and Dicer enzymes, ultimately being incorporated into the RNA-induced silencing complex (RISC) which mediates regulatory effects[1][2][4][5]. While many microRNAs play established roles in diseases such as cancer, inflammation, and development, specific biological functions or disease associations for MIR4308 have not been characterized in current literature and databases. Thus, MIR4308 is formally classified as a regulatory non-coding RNA rather than a classic therapeutic target or biomarker[4][5]. No evidence was found for MIR4308 targeting, interacting drugs, mechanism of action beyond canonical miRNA activity, validated biomarkers, or notable safety concerns specific to this miRNA. The name, classification, and general function are consistent with established microRNA biology; the main limitation is a lack of specific functional or disease association data.

Other names

hsa-mir-4308MIR4308microRNA 4308